Remove 2025 Remove Epilepsy Remove Safety Remove Topical
article thumbnail

Article: Who is Impacted if Marijuana is Reclassified as a Schedule II Drug

Cannabis Law Report

She is currently a law school professor teaching Marijuana and the Law at California Western School of Law and researcher under a contract with NHTSA and NORC on the topic of the prosecution of drugged driving cases. billion in federal tax revenue between 2017 and 2025. That is another topic to be explored. [i] i] [link]. [ii]

article thumbnail

New York Medical Marijuana Guide

Cannabis Law Report

The Department of Health conducted a formal study on this topic in 2018. The researchers found overwhelming benefits for the economy, public health and safety, and thusly recommended the development of a comprehensive regulatory framework for marijuana use in the city. . Current situation and fight for recreational use.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Is CBD safe? FDA Issues Warning Letters to Companies

Puff Puff Post

The FDA’s Consumer Update reiterated that, with the exception of Epidiolex (a CBD drug for rare forms of epilepsy), the FDA hasn’t approved any other forms of CBD. billion, and is expected to grow dramatically by 2025. Walgreens issued a similar statement on their website announcing their intention to carry certain topicals.

CBD 52
article thumbnail

Meritas Law Firms Worldwide Article: Global Cannabis Industry: The Essential Primer

Cannabis Law Report

Retailers such as Walgreens, CVS, Rite Aid, Kroger, Safeway, Nordstrom, and DSW are selling or plan to sell CBD-infused topical lotions, cosmetics, and even edibles where they are legally able to do so. billion in 2025, according to Grandview Research. the form the finished product can take (edibles, topicals, etc.).

Law 40